The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States-Reference-Cited by-同舟云学术

The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States

Published:2015-12-09 Issue:6 Volume:62 Page:784-791
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Girouard Michael P.,Sax Paul E.,Parker Robert A.,Taiwo Babafemi,Freedberg Kenneth A.,Gulick Roy M.,Weinstein Milton C.,Paltiel A. David,Walensky Rochelle P.

Funder

National Institutes of Health

NIH

National Institute of Allergy and Infectious Diseases

Massachusetts General Hospital Research Scholars Award

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/62/6/784/17352775/civ981.pdf

Reference39 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2015. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf . Accessed 10 April 2015.

2. Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

3. Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

4. Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)

5. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda;Value in Health Regional Issues;2024-11

2. Characteristics and real-world medication persistence of people living with HIV treated with DTG/3TC or BIC/FTC/TAF: a hospital claims database study in Japan;Frontiers in Medicine;2024-09-10

3. Two-drug regimens for the treatment of HIV in Africa;The Lancet HIV;2024-06

4. Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses;Infectious Diseases and Therapy;2024-04

5. Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study;Infectious Diseases and Therapy;2024-04